Providers/LillyDirect

LillyDirect

$299 to $449/moPrice checked October 2026

Eli Lilly's own self-pay channel for Zepbound. Vials or pens, priced by dose strength rather than flat.

Last reviewed September 2026

How it works

The manufacturer selling its own product directly for cash, with no insurance involved. You still need a prescription from a clinician. Medication arrives as single-dose vials rather than the autoinjector pens dispensed through pharmacies.

What you get

  • FDA-approved Zepbound, made by Lilly
  • Single-dose vials, and KwikPens at the same self-pay prices
  • No insurance involvement
  • No clinician provided, so you bring your own prescription

What to check before signing up

  • Pricing is set per dose strength rather than flat, so what you pay rises as you titrate upward.
  • The lower prices on higher doses have been conditional on refilling within a set window. Missing that window has meant paying more.
  • Self-pay pricing in this channel has changed several times since it launched. Check the current figure on the site itself rather than relying on any published summary, including ours.
  • Vials mean drawing your own dose. Pens do not, and both are now sold in this channel, so confirm which one your order is for.

Best for

People who want manufacturer-supplied brand medication without insurance, and are comfortable drawing from a vial.

Our take

The cheapest route to genuine brand tirzepatide. It still costs more than the compounded subscriptions on this page, but the gap has narrowed considerably since this channel opened, and what the difference buys is an FDA-approved finished product rather than a compounded preparation.

Sources

Educational only. Nothing here is medical advice, and nothing here substitutes for a conversation with a licensed clinician who knows your history. Dosing, side effects and outcomes vary between people.